Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
N/A
-780 Reduced 29.22%
1,889 $0
Q3 2022

Nov 14, 2022

SELL
$0.1 - $0.75 $3,721 - $27,912
-37,216 Reduced 93.31%
2,669 $0
Q2 2022

Aug 08, 2022

BUY
$0.3 - $2.74 $8,919 - $81,460
29,730 Added 292.76%
39,885 $18,000
Q1 2022

May 10, 2022

BUY
$2.13 - $3.85 $2,534 - $4,581
1,190 Added 13.27%
10,155 $23,000
Q4 2021

Feb 11, 2022

SELL
$3.39 - $6.76 $6,034 - $12,032
-1,780 Reduced 16.57%
8,965 $35,000
Q3 2021

Nov 08, 2021

SELL
$2.1 - $5.19 $17,980 - $44,436
-8,562 Reduced 44.35%
10,745 $35,000
Q2 2021

Aug 09, 2021

BUY
$4.68 - $7.39 $15,298 - $24,157
3,269 Added 20.38%
19,307 $90,000
Q1 2021

Apr 28, 2021

BUY
$6.81 - $10.55 $109,218 - $169,200
16,038 New
16,038 $119,000
Q4 2020

Feb 09, 2021

SELL
$3.33 - $7.18 $72,780 - $156,926
-21,856 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$2.28 - $6.6 $12,004 - $34,749
-5,265 Reduced 19.41%
21,856 $81,000
Q4 2019

Feb 13, 2020

SELL
$3.34 - $5.51 $76,713 - $126,553
-22,968 Reduced 45.85%
27,121 $128,000
Q3 2019

Oct 17, 2019

BUY
$2.23 - $4.61 $27,210 - $56,251
12,202 Added 32.21%
50,089 $160,000
Q2 2019

Aug 05, 2019

BUY
$3.59 - $8.37 $43,535 - $101,502
12,127 Added 47.08%
37,887 $156,000
Q1 2019

Apr 16, 2019

SELL
$7.71 - $11.24 $322,887 - $470,719
-41,879 Reduced 61.92%
25,760 $207,000
Q4 2018

Jan 17, 2019

BUY
$7.3 - $18.3 $6,132 - $15,372
840 Added 1.26%
67,639 $493,000
Q3 2018

Nov 02, 2018

BUY
$9.77 - $17.15 $649,861 - $1.14 Million
66,516 Added 23503.89%
66,799 $0
Q2 2018

Jul 24, 2018

SELL
$5.43 - $9.83 $7,406 - $13,408
-1,364 Reduced 82.82%
283 $0
Q1 2018

May 03, 2018

SELL
$5.79 - $8.86 $265,830 - $406,780
-45,912 Reduced 96.54%
1,647 $10,000
Q4 2017

Feb 02, 2018

SELL
$5.88 - $9.09 $8,661 - $13,389
-1,473 Reduced 3.0%
47,559 $368,000
Q3 2017

Oct 20, 2017

BUY
$7.55 - $9.43 $370,191 - $462,371
49,032
49,032 $421,000

About Endo International plc


  • Ticker ENDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 235,143,008
  • Market Cap $68.8M
  • Description
  • Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...
More about ENDP
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.